Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Van Gerpen, J. A.
Right arrow Articles by Wszolek, Z. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Gerpen, J. A.
Right arrow Articles by Wszolek, Z. K.
Related Collections
Right arrow MRI
Right arrow All Clinical Neurology
Right arrow All Psychiatric disorders
Right arrow Assessment of cognitive disorders/dementia
Right arrow All Genetics
NEUROLOGY 2008;71:925-929
© 2008 American Academy of Neurology

Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids

J. A. Van Gerpen, MD, C. Wider, MD, D. F. Broderick, MD, D. W. Dickson, MD, L. A. Brown, BA and Z. K. Wszolek, MD

From the Departments of Neurology (J.A.V.G., C.W., L.A.B., Z.K.W.), Radiology (D.F.B.), and Pathology (D.W.D.), Mayo Clinic, Jacksonville, FL.

Address correspondence and reprint requests to Dr Wszolek, Mayo Clinic, Neurology, 4500 San Pablo Rd., Jacksonville, FL 32224 wszolek.zbigniew{at}mayo.edu

Objective: To report a new American family with hereditary diffuse leukoencephalopathy with spheroids (HDLS), including serial, presymptomatic and symptomatic, cranial MRIs from the proband.

Methods: We report clinical and genealogic investigations of an HDLS family, sequential brain MRIs of the proband, and autopsy slides of brain tissue from the proband’s father.

Results: We identified seven affected family members (five deceased). The mean age at symptomatic disease onset was 35 years (range: 20–57), and the mean disease duration was 16 years (range: 3–46). Five affected individuals initially manifested memory disturbance and behavioral changes, whereas two experienced a mood disorder as their presenting symptom. Our proband’s father had been diagnosed clinically with vascular dementia, but his brain autopsy was consistent with HDLS. The proband had a cranial MRI prior to symptom onset, with two subsequent MRIs performed during follow-up. These serial images reveal a progressive, confluent, frontal-predominant leukoencephalopathy with symmetric cortical atrophy.

Conclusions: The proband of our newly identified hereditary diffuse leukoencephalopathy with spheroids (HDLS) kindred had subtle evidence of an incipient leukoencephalopathy on a presymptomatic cranial MRI. Conceivably, MRI may facilitate identifying affected presymptomatic individuals within known HDLS kindreds, increasing the likelihood of isolating the causative genes.

GLOSSARY: DLS = diffuse leukoencephalopathy with spheroids; FLAIR = fluid-attenuated inversion recovery; HDLS = hereditary diffuse leukoencephalopathy with spheroids; LENAS = leukoencephalopathy with neuroaxonal spheroids; LFB = Luxol fast blue; NAL = neuroaxonal leukodystrophy; POLD = pigmentary type of orthochromatic leukodystrophy.

C.W. is supported by the Swiss National Science Foundation, Parkinson Switzerland, and the Robert and Clarice Smith Fellowship program. Z.K.W., J.A.V.G., and D.W.D. are supported by the Morris K. Udall Center of Excellence for PD Research (P50-NS40256). D.W.D. is supported by the Mayo Clinic ADRC grant P50-AG16574. Z.K.W. and D.W.D. are supported by the Pacific Alzheimer Research Foundation (PARF) grant C06-01.

Disclosure: The authors report no disclosures.

Received March 31, 2008. Accepted in final form June 12, 2008.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.